Health
NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial – News-Medical.Net
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal…
The coronavirus disease 2019 (COVID-19) pandemic continues to spread worldwide, with a new highly infectious strain identified in the UK, causing surges of new cases. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 can cause mild to severe illness, while some do not experience any symptoms at all.
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal antibody…
-
Noosa News20 hours agoBrisbane flights cancelled as severe weather set to lash coast
-
Business23 hours agoWhat could happen to the big 4 banks in FY26?
-
Business21 hours ago2 ASX ETFs to benefit from the resurgence of AI
-
Noosa News15 hours agoHero rescuer reveals terrifying details of horror shark attack at Cabarita Beach in NSW